GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Invent Medic Sweden AB (XSAT:IMS) » Definitions » EPS (Diluted)

Invent Medic Sweden AB (XSAT:IMS) EPS (Diluted) : kr-0.22 (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Invent Medic Sweden AB EPS (Diluted)?

Invent Medic Sweden AB's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was kr-0.05. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.22.

Invent Medic Sweden AB's EPS (Basic) for the three months ended in Mar. 2024 was kr-0.05. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.22.

Invent Medic Sweden AB's EPS without NRI for the three months ended in Mar. 2024 was kr-0.05. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.22.

During the past 3 years, the average EPS without NRIGrowth Rate was 40.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 24.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Invent Medic Sweden AB's highest 3-Year average EPS without NRI Growth Rate was 40.40% per year. The lowest was -35.70% per year. And the median was 4.10% per year.


Invent Medic Sweden AB EPS (Diluted) Historical Data

The historical data trend for Invent Medic Sweden AB's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invent Medic Sweden AB EPS (Diluted) Chart

Invent Medic Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial -1.07 -1.00 -0.72 -0.45 -0.21

Invent Medic Sweden AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.05 -0.06 -0.06 -0.05

Competitive Comparison of Invent Medic Sweden AB's EPS (Diluted)

For the Medical Devices subindustry, Invent Medic Sweden AB's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invent Medic Sweden AB's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Invent Medic Sweden AB's PE Ratio distribution charts can be found below:

* The bar in red indicates where Invent Medic Sweden AB's PE Ratio falls into.



Invent Medic Sweden AB EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Invent Medic Sweden AB's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-8.532-0)/40.171
=-0.21

Invent Medic Sweden AB's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.927-0)/38.540
=-0.05

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invent Medic Sweden AB  (XSAT:IMS) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Invent Medic Sweden AB EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Invent Medic Sweden AB's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Invent Medic Sweden AB (XSAT:IMS) Business Description

Traded in Other Exchanges
N/A
Address
Medicon Village, Scheele path 2, Lund, SWE, 223 81
Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.

Invent Medic Sweden AB (XSAT:IMS) Headlines

From GuruFocus

Well-Known Companies Reach 52 Week Highs

By yifan900 yifan900 10-11-2016

Weekly Insider Sells Highlight: IMS, NOW, BMY, EA

By James Xiao James Xiao 08-11-2015

5 Companies Reach 52-Week Highs

By yifan900 yifan900 02-13-2018

The Big 3: Larry Robbins' Top 2nd-Quarter Buys

By James Li James Li 08-16-2016

Healthcare Informatics: A Value Investor's Perspective

By Thomas Macpherson Thomas Macpherson 10-23-2015